Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mllerian hormone
Author
dc.contributor.author
Villarroel, C.
Author
dc.contributor.author
Merino, P. M.
Author
dc.contributor.author
López, P.
Author
dc.contributor.author
Eyzaguirre, F. C.
Author
dc.contributor.author
Van Velzen, A.
Author
dc.contributor.author
Iñíguez Vila, Germán
Author
dc.contributor.author
Codner Dujovne, Ethel
Admission date
dc.date.accessioned
2019-03-11T13:02:22Z
Available date
dc.date.available
2019-03-11T13:02:22Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Human Reproduction, Volumen 26, Issue 10, 2018, Pages 2861-2868
Identifier
dc.identifier.issn
14602350
Identifier
dc.identifier.issn
02681161
Identifier
dc.identifier.other
10.1093/humrep/der223
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165337
Abstract
dc.description.abstract
Background The significance of polycystic ovarian morphology (PCOM) during adolescence is not clear. The aim of this study was to determine the relationship between PCOM and anti-Mllerian hormone (AMH), inhibin B, testosterone and insulin levels in healthy girls during the second decade of life. We also determined whether AMH could be used as a surrogate marker of PCOM during adolescence. Methods Seventy-four non-obese adolescents (age range: 13.5-19.75 years old) with regular menstrual cycles participated in this study. Transabdominal ultrasound and blood samples were obtained during the follicular phase. Results PCOM was present in 33.8 of the subjects. Girls with PCOM had higher AMH levels than girls without PCOM (72.5 ± 6.1 versus 33.4 ± 2.6 pmol/l; P < 0.0001) and lower FSH levels (5.4 ± 0.3 versus 6.2 ± 0.2 mUI/ml; P < 0.036). Similar levels of inhibin B, androgens and LH were observed in girls with and without PCOM. PCOM prevalence and AMH levels were not associated with age (P